Hummelstown, PA, United States of America

Sprague W Hazard, Iii

This inventor holds 4 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: The Penn State Research Foundation. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sprague W Hazard, Iii. Retrieved from https://idiyas.com/inventor/sprague-w-hazard-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Sprague W. Hazard, III in Hydrocephalus Treatment**

Introduction

Sprague W. Hazard, III, based in Hummelstown, Pennsylvania, is a distinguished inventor with a specific focus on advancements in medical technology. With a total of three patents to his name, Hazard has made significant contributions to the field, particularly in the treatment of hydrocephalus, a condition characterized by an accumulation of cerebrospinal fluid in the brain.

Latest Patents

Hazard's innovation portfolio includes cutting-edge patents that demonstrate his commitment to improving patient care. His most recent invention, titled "Surgical method, device, system and kit for the treatment of hydrocephalus," presents a modular cerebrospinal fluid (CSF) drain system designed to treat hydrocephalus effectively while avoiding penetration of the gray matter of the brain. This innovative system incorporates various modular components, such as a subarachnoid space (SAS) inlet drain implant, SAS implant plug, connector implant, dural venous sinus (DVS) implant plug, and DVS outlet drain implant. When utilized, these components work together to facilitate the flow of cerebrospinal fluid from the subarachnoid space through to the cerebral venous sinuses.

Moreover, Hazard has developed the "Bedside stereotactic ultrasound guidance device, system and method," which provides fixation devices and locking assemblies that enhance the accuracy of medical device insertion. This invention incorporates advanced detection means to accurately locate a patient's internal anatomy, ensuring precise targeting and reliable locking mechanisms to maintain accuracy throughout medical procedures.

Career Highlights

Sprague W. Hazard, III is currently affiliated with the Penn State Research Foundation, where he leverages his expertise to advance research initiatives and facilitate innovative solutions in healthcare. His work not only emphasizes his technical proficiency but also reflects a deep commitment to addressing pressing medical challenges.

Collaborations

Throughout his career, Hazard has collaborated with notable colleagues, including Barry M. Fell and Pratik Rohatgi. These collaborations bring together diverse expertise, enriching the research environment and contributing to the development of groundbreaking medical technologies.

Conclusion

In summary, Sprague W. Hazard, III stands out as a pioneering inventor in the medical field, particularly in the sphere of hydrocephalus treatment. His significant contributions through his patents demonstrate not just innovation, but also a dedication to improving patient outcomes through advanced medical technology. As he continues to collaborate and push the boundaries of research, his work promises to impact countless lives positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…